Clinical Trial Update: A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study to evaluate the efficacy and safety of KP-001 versus placebo in patients aged 2 years and older with venous malformations, lymphatic malformations…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cloves Syndrome
• Klippel-trenaunay Syndrome
• Lymphatic Malformations
• Venous Malformations

Drugs mentioned

• KP-001

Snippet

Sponsor: Kaken Pharmaceutical | Conditions: Venous Malformations, Lymphatic Malformations | Phase 3 | Status: NOT_YET_RECRUITING